Skip to main content
. 2018 Mar 5;11(4):451–462. doi: 10.1007/s40271-018-0302-z

Table 2.

Disease of interest per stakeholder category: phase I

Disease of interest Stakeholder category Mean (total)* (%)
Parents/patients Physicians PCORI awardees Bioinformaticists Scientists Others
1. Autism 4 (33.3%) 1 (11.1%) 1 (25%) 8 (53.3%) 5 (71.4%) 39.40
2. CVD 4 (33.3%) 4 (44.4%) 3 (50%) 2 (50%) 3 (20%) 27.30
3. Cancer 6 (50%) 3 (33.3%) 3 (50%) 1 (25%) 4 (26.7%) 1 (14.2%) 27.30
4. Other 27.30
Details for “Other” disease category
Turner syndrome 1 (8.3%)
Metabolic disease 1 (8.3%)
Rehabilitation medicine 1 (11.1%) 1 (6.7%)
Nephrology 1 (11.1%)
Infectious Diseases 1 (11.1%) 1 (16.7%) 1 (6.7%)
Research Informatics 1 (25%) 1 (6.7%) 1 (14.2%)
Sleep disorders 1 (6.7%)
Genetics 1 (6.7%)
Bipolar disorder 1 (14.2%)
ADHD 1 (14.2%)
Allergies 1 (14.2%)
Asthma 1 (14.2%)

Numbers and percentages are shown per each stakeholder category

ADHD attention-deficit hyperactivity disorder, CAB community advisory board, CVD cardiovascular disease, PCORI Patient-Centered Outcomes Research Institute

*The average total was calculated based on the total number of CAB members (N = 33). Of note, some CAB members selected more than one disease category